GLP1R and obesity disorder: Substantial evidence now supports their role in improving cardiovascular outcomes, particularly among patients with obesity-related HFpEF Mechanistically, GLP-1 RAs influence several central pathways in HF pathophysiology, including mitochondrial energetics, calcium handling neurohormonal activation inflammation, fibrosis and vascular function.